Archive: 24/05/2017

Drugmaker paying $33M over recalled nonprescription meds

Johnson & Johnson has reached a $33 million settlement with 42 states, resolving allegations the health care giant sold numerous nonprescription medicines that didn't meet federal quality requirements for a couple of years.

Ads, not research, create some best-selling drugs

An overhead light drawing attention to his face, actor Danny Glover starts to cry, dropping his head into one hand - and then, he abruptly switches over to deep belly laughs, before resuming a straight face. "When I act, ...

New drug approved for all cancers with genetic marker

(HealthDay)—Keytruda (pembrolizumab) has been approved by the U.S. Food and Drug Administration to treat any cancer that has a certain genetic biomarker, regardless of where in the body the cancer originated.

page 2 from 10